Advocacy Committee

Makes recommendations on the Society’s response to global opportunities to support or inform research, education, technologies, and policies that improve access to care and outcomes for patients with advanced heart and lung disease.

ISHLT members can log in to see contact information for each of the committee members and representatives listed below. Only ISHLT members have access to this information.

Headshot of Stuart Sweet

Stuart Sweet, MD, PhD (2025)

Chair
Washington University in St. Louis
Saint Louis, MO USA

Alan Betensley, MD (2025)

Vice Chair
Northwestern University
Chicago, IL USA
Headshot of Laurie Snyder

Laurie Snyder, MD, MHS (2024)

Board of Directors Liaison
Duke University
Durham, NC USA
Headshot of Rayid Abdulqawi

Rayid Abdulqawi, MD, PhD (2025)

Member
King Faisal Specialist Hospital and Research Centre
Riyadh, Saudi Arabia
Headshot of Alexander Bernhardt

Alexander Bernhardt, MD (2025)

Member
University Heart and Vascular Center Hamburg
Hamburg, Germany
Carles Diez-Lopez headshot

Carles Diez-Lopez, MD, PhD Student (2025)

Member
Bellvitge University Hospital
Barcelona, Spain
Christiana Gjelaj Headshot

Christiana Gjelaj, DNP (2025)

Member
Montefiore medical center

Image Coming Soon

Anita Kelkar, MD, MPH (2025)

Member
Wake Forest Baptist Health
Greensboro, NC USA
Headshot of Nicholas Kolaitis

Nicholas Kolaitis, MD (2025)

Member
University of California, San Francisco
San Rafael, CA USA
Sandra Lindstedt headshot

Sandra Lindstedt, MD, PhD (2025)

Member
Wallenberg Centre for Molecular Medicine, Lund University
Lund, Sweden
Image Coming Soon

Leslie Seijo, MD (2025)

Member
University of California San Francisco
San Francisco, CA USA
Image Coming Soon

Nikki Singh, MD (2025)

Member
Children's Wisconsin
Milwaukee, WI USA
Image Coming Soon

Johannes Steiner, MD (2025)

Member
OHSU
Portland, OR USA
Aaron Adair headshot

Aaron Adair,

ISHLT Staff Liaison
ISHLT

The ISHLT Advocacy Committee makes recommendations on the Society’s response to global opportunities to support or inform research, education, technologies, and policies that improve access to care and outcomes for patients with advanced heart and lung disease.

OPTN Comment Library

Policies